Results for tag: "Encephalitis Vaccines"

The Encephalitis vaccines market is an integral part of the broader diagnostics and preventive healthcare sector, focusing on the immunization against various forms of encephalitis, which is an inflammation of the brain often caused by viruses. The utilization of these vaccines is crucial in the prevention and control of encephalitis outbreaks. This market encompasses the development, production, and distribution of vaccines that protect against encephalitis-causing pathogens such as Japanese encephalitis virus (JEV), tick-borne encephalitis virus (TBEV), and other viruses. Diagnostics play a key role in encephalitis management by identifying the causative agent and determining the end user's need for vaccination. Effective diagnostic measures are essential in mapping the prevalence of the disease, enabling healthcare providers to strategize vaccination programs. Encephalitis vaccines thereby bridge the gap between diagnostics and prevention, reducing the incidence and severity of the disease. Several notable companies are active in the encephalitis vaccines market, contributing to the research, development, and supply of these life-saving products. Among these companies are Sanofi Pasteur, which provides vaccines for Japanese encephalitis, and Pfizer, known for its contributions to infectious disease prevention. Additionally, Valneva is recognized for its work on vaccines for tick-borne encephalitis, while Bharat Biotech offers vaccines tailored to the Indian subcontinent, where certain encephalitides are more prevalent. Show Less Read more